Blue Owl Capital Corporation Common Stock OBDC 深 滬
等待開盤 11-26 09:30:00 美东时间
12.88
+0.230
+1.82%
華盛通- 最 高12.89
- 今 開12.68
- 成交量 715.75万股
- 最 低 12.58
- 昨 收 12.65
- 總市值 65.82亿
- 52周最高 14.795
- 市盈率 靜 8.44
- 換手率 0.00%
- 52周最低 11.34
- 委 比 84.62%
- 總股本 5.11亿
- 歷史最高 14.54
- 量 比 0.64
- 振 幅 2.45%
- 歷史最低 -0.50
- 每 手 1
- 風險率 0.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Blue Owl Capital, Blue Owl Capital Corp. II Announce Merger Termination
Blue Owl Capital Corporation (NYSE:OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") today announced that the previously proposed merger of OBDC and OBDC II has been terminated, with plans to reevaluate
11-19 22:12
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Blue Owl Capital Q3 Adj. EPS $0.36 Misses $0.40 Estimate, Sales $446.307M Miss $467.190M Estimate
Blue Owl Capital (NYSE:OBDC) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.40 by 9.09 percent. This is a 2.86 percent increase over earnings of $0.35 per share from the
11-06 07:08
Blue Owl Capital, Blue Owl Capital Corporation I Sign Merger Agreement
Blue Owl Capital Corporation (NYSE: OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") announced today that they have entered into a definitive merger agreement, with OBDC as the surviving company,
11-06 05:38
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Clear Street Initiates Coverage On Blue Owl Capital with Buy Rating, Announces Price Target of $15
Clear Street analyst Mickey Schleien initiates coverage on Blue Owl Capital (NYSE:OBDC) with a Buy rating and announces Price Target of $15.
09-05 17:32
美股9月收息策略：最高股息率超15%！默沙东、惠普、必和必拓等180多家高分红股如何布局？
最高股息率超15%！默沙东、惠普、必和必拓等180多家美股公司即将派息；投资者若想赚取股息，可趁未除净适时部署，一文速览派息名单>>
09-01 19:16
